touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • Immunotherapy and evolving approaches for basal cell carcinoma

    touchEXPERT OPINIONS for touchONCOLOGY

    Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how novel immunotherapeutic approaches within the emerging clinical study landscape may improve patient care.

    The experts

    • Prof. Axel Hauschild, University Hospital Schleswig-Holstein, Kiel, Germany
  • Dr Emily Ruiz, Brigham and Women’s Hospital, Boston, MA, USA
  • Prof. Ketty Peris, Catholic University of Rome, Rome, Italy

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. This activity is jointly provided by USF Health and touchIME.

    37 min
  • What is the long-term picture for patients with EGFR-mutant NSCLC?

    touchMDT for touchONCOLOGY

    Listen to a medical oncologist and an oncology nurse practitioner discuss how to involve the patient in treatment decisions and the role of the multidisciplinary team in keeping abreast of the latest data.

    The multidisciplinary team

    • Medical oncologist: Dr David Planchard, France 
  • Oncology nurse practitioner: Ms Beth Sandy, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/evolving-role-mdt-early-nsclc/

    14 min
  • What are the implications of adjuvant therapy data on biomarker evaluation?

    touchMDT for touchONCOLOGY

    Listen to a medical oncologist and a pathologist discuss the benefits of biomarker testing in early and locally advanced NSCLC.

    The multidisciplinary team

    • Medical oncologist: Dr David Planchard, France 
  • Molecular pathologist: Prof. Albrecht Stenzinger, Germany

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/evolving-role-mdt-early-nsclc/

    15 min
  • How is the advent of adjuvant therapy in NSCLC changing our approach to surgery?

    touchMDT for touchONCOLOGY

    Listen to a medical oncologist, a pulmonologist and a thoracic surgeon as they assess the suitability of a patient with NSCLC for surgery and expanding treatment options.

    The multidisciplinary team

    • Medical oncologist: Dr David Planchard, France 
  • Pulmonologist: Prof. Johan Vansteenkiste, Belgium
  • Thoracic surgeon: Dr Masahiro Tsuboi, Japan

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/evolving-role-mdt-early-nsclc/

    17 min
  • Patient education, evidence-based treatment and biomarkers in HFrEF

    touchPANEL DISCUSSION for touchCARDIO

    Listen to leading experts discuss how patients can be best supported following a diagnosis of HFrEF, how to implement evidence-based therapies into practice including the potential impact of emerging therapies on treatment selection, and the role of biomarkers in diagnosing, monitoring and determining treatment course for individuals with HFrEF.

    The experts

    • Prof. Piotr Ponikowski, Wrocław Medical University, Wrocław, Poland
  • Prof. Adriaan A Voors, University Medical Centre Groningen, Groningen, The Netherlands
  • Dr Stephen Greene, Duke University, Durham, NC, USA

    • This touchPODCAST is for HCPs only.

    Funding for this touchPODCAST is from an unrestricted independent educational grant from Bayer, Merck & Co and AstraZeneca. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchcardioime.org/aiming-for-improved-outcomes-in-hfref

    36 min
  • Highlights from EHA2021 Virtual 2021: Focus on MDS and AML

    touchCONGRESS for touchONCOLOGY

    Listen to Prof. Uwe Platzbecker (Germany) cover key data presented at EHA2021 Virtual on new and emerging treatments for the improvement of outcomes in higher-risk MDS and newly diagnosed AML, including expert insights and interpretation from Prof. Valeria Santini (Italy) and Prof. Andrew Wei (Australia).

    This touchPODCAST is for HCPs only.

    Funding for this touchPODCAST is from an unrestricted independent educational grant from Novartis. The content was led by touchIME.    

    For further information visit our website: https://touchoncologyime.org/MDS-AML-EHA2021-touchcongress/

    1 hr 5 min
  • Perspectives on the latest data for novel lipid-lowering therapies

    touchMDT for touchCARDIO

    Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia 

    The multidisciplinary team

    • Primary care physician: Dr Yassir Javaid, UK 
  • Cardiologist: Dr Constantine Kosmas, USA
  • Endocrinologist: Professor Lawrence Leiter, Canada

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchcardioime.org/novel-lipid-lowering-therapies-for-reducing-ASCVD-risk/

    20 min
  • Perspectives on how novel lipid-lowering therapies may help address current unmet needs

    touchMDT for touchENDOCRINOLOGY

    Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel lipid-lowering therapies may help 

    The multidisciplinary team

    • Endocrinologist: Professor Lawrence Leiter, Canada
  • Cardiologist: Dr Constantine Kosmas, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland.  This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: 

    https://touchendocrinologyime.org/novel-lipid-lowering-therapies-for-reducing-ascvd-risk/

    15 min
  • Perspectives on the risk factors for ASCVD and guidelines for dyslipidaemia management

    touchMDT for touchENDOCRINOLOGY

    Listen to key experts from a multidisciplinary team discuss the risk factors and lipoproteins associated with ASCVD and guideline recommendations for the management of patients with dyslipidemia

    The multidisciplinary team

    • Cardiologist: Dr Constantine Kosmas, USA
  • Primary care physician: Dr Yassir Javaid, UK 

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This medical education is provided by touchIME.

     

    14 min
  • Perspectives on the latest data for novel lipid-lowering therapies

    touchMDT for touchCARDIO

    Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia 

    The multidisciplinary team

    • Primary care physician: Dr Yassir Javaid, UK 
  • Cardiologist: Dr Constantine Kosmas, USA
  • Endocrinologist: Professor Lawrence Leiter, Canada

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This medical education is provided by touchIME.

    For further information visit our website: https://touchcardioime.org/novel-lipid-lowering-therapies-for-reducing-ascvd-risk//

    20 min

About touchPODCAST

From the publisher's feed

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.